ClinicalTrials.Veeva

Menu

Noninvasive Positive Pressure Ventilation in Moderate Acute Respiratory Distress Syndrome

B

Beijing Hospital

Status

Completed

Conditions

Acute Respiratory Distress Syndrome

Treatments

Procedure: invasive mechanical ventilation
Procedure: noninvasive positive pressure ventilation (NPPV)

Study type

Interventional

Funder types

Other

Identifiers

NCT01585922
20120418BIRM

Details and patient eligibility

About

In order to identify the effect of noninvasive positive pressure ventilation (NPPV) on decreasing inflammatory response, improving the pathophysiological manifestation and reducing the morbidity and mortality in the moderate acute respiratory distress syndrome (ARDS) patients, the investigators conduct this clinical trial comparing NPPV with invasive mechanical ventilation in more than twenty ICUs in China.

Enrollment

120 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. acute onset
  2. a clinical presentation of respiratory distress
  3. arterial oxygen tension/inspired oxygen fraction (PaO2/FiO2) between 200 mmHg to 300 mmHg. The arterial oxygen tension will be measured in fifteen minutes after NPPV (CPAP 5 cmH2O) was used to the patients stably
  4. presence of bilateral pulmonary infiltrate on chest radiograph
  5. no evidence of left heart failure as assessed by echocardiography and/or a pulmonary artery wedge pressure( PAWP) < 18 mmHg

Exclusion criteria

  1. age > 70 years or < 18 years
  2. PaCO2 > 50mmHg
  3. Glasgow Coma Scale (GCS)< 11
  4. Upper airway/facial deformity or injury
  5. pneumothorax or pneumomediastinum
  6. unable to spontaneously clear secretions from their airway
  7. respiratory arrest
  8. severe ventricular arrhythmia or active myocardial ischemia
  9. severe organ dysfunction (including gastrointestinal hemorrhage, disseminated intravascular coagulation, hepatic and renal dysfunction, SOFA score > 1)
  10. severe chronic lung diseases(COPD, Asthma or ILD, et al)
  11. end-stage patients who are expected to survive less than six months
  12. severe abdominal distension
  13. refuse to receive NPPV
  14. unable to cooperate with NPPV

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

120 participants in 2 patient groups

NPPV
Experimental group
Description:
Use the NPPV to treat moderate ARDS
Treatment:
Procedure: noninvasive positive pressure ventilation (NPPV)
IMV
Active Comparator group
Description:
Use invasive mechanical ventilation in treating the patients allocated to this group.
Treatment:
Procedure: invasive mechanical ventilation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems